Paragonix Technologies, a pioneer in organ transplant technologies and organ procurement services, announces today its BAROguard® System has been recognized as one of TIME’s Best Inventions of 2024 in the medical care category. The annual list celebrates the top 200 innovations shaping the future, addressing critical challenges, and transforming lives across various fields, including healthcare, AI, and green energy.
The BAROguard system is the first of its kind. The system integrates clinically proven hypothermic preservation techniques with active airway management control to maintain optimal conditions for donor lungs during transport. Equipped with real-time tracking and reporting, BAROguard delivers continuous data on organ status to surgeons and transplant teams throughout transit. In August 2023, Paragonix Technologies received FDA 510(k) clearance for BAROguard and completed its first-in-human case at Duke University Medical Center in November of the same year.
“The organ transplantation industry has advanced tremendously in recent years, and we’re proud to be at the forefront of innovation in this space,” said Lisa Anderson, Ph.D., president of Paragonix Technologies. “With donor waitlists continuing to grow, it’s crucial to offer technology that safeguards each and every organ. Being recognized alongside so many groundbreaking inventions by TIME highlights the transformative potential of BAROguard and our other preservation devices to make a meaningful impact for millions of transplant recipients, donor families, and healthcare professionals.”
TIME evaluated nominations based on originality, impact, and efficacy, and chose the BAROguard System as one of 2024’s most promising innovations in healthcare. The full TIME Best Inventions list for 2024 is available at time.com/best-inventions-2024.
For more information about Paragonix Advanced Organ Preservation devices, please visit www.paragonix.com.
About Paragonix Technologies
Paragonix Technologies is a leading developer, manufacturer, and service provider in the organ transplant industry, establishing a novel approach to organ preservation. Paragonix Technologies provides Advanced Organ Preservation (“AOP”) devices that safeguard donor organs during the journey between donor and recipient patients. Our FDA-cleared and CE-marked devices incorporate clinically proven and medically trusted cold preservation techniques that allow unprecedented physical and thermal protection to the organ during transit. All Paragonix AOP devices are natively integrated with our novel digital app, delivering real-time organ tracking data and monitoring logistics for transplant teams seeking a secure and centralized solution. For more information, visit www.paragonix.com.
Follow us on Twitter: @ParagonixSherpa
Connect with us on LinkedIn: Paragonix Technologies
Like Us on Facebook: Paragonix Technologies
View source version on businesswire.com: https://www.businesswire.com/news/home/20241104491763/en/